Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis

Table 1 Descriptive summary of 18 studies included in the meta-analysis of the prevalence first line treatment failure in Ethiopia 2019

Authorship	Publication (yr)	Study area /Region	Study population	Study period	Sample	Prevalence at 95% CI
Hail et al. [21]	2016	Oromia	Adult	2007–2014	4809	9.4 (8.6, 10.2)
Ayalew et al. [17]	2016	Amhara	Adult	2011–2015	340	4.1 (2.0, 6.2)
Sisay et al. [20]	2017	Addis Ababa	Adult	2011–2016	595	21.5 (18.2, 24.8)
Melsew et al. [30]	2013	Amhara	Adult	Jan-Apr,2007	509	21.0 (17.5, 24.5)
Teshome et al. [27]	2015	Addis Ababa	Adult	2009–2013	525	19.8 (16.4, 23.2)
Yassin et al. [37]	2017	Oromia	Child	2006–2015	269	18.8 (14.1, 23.5)
Sisay et al. [23]	2017	Amhara	Child	2010–2016	824	7.7 (5.9, 9.5)
Bach et al. [25]	2012	Addis Ababa	Child	2005–2011	1186	14.1 (12.1, 16.1)
Yirdaw et al. [38]	2015	SNNP	Mixed	2004–2012	1321	17.6 (15.6, 19.7)
Assefa et al. [15]	2014	Amhara	Adults	2007–2008	400	22.2 (18.1, 26.3)
Teshome et al. [28]	2015	Addis Ababa	Adult	2007–2009	293	15.7 (11.5, 19.9)
Bekelech et al. [18]	2015	Oromia	Adult	2006–2013	828	6.8 (5.1, 8.5)
Brhane et al. [19]	2017	Amhara	Mixed	Aug-Sep, 2016	421	10.7 (7.8, 13.7)
Zeleke et al. [16]	2016	Amhara	Child	Sept-Dec,2014	225	18.2 (13.2, 23.2)
Agezew et al. [24]	2019	Amhara	Adult	2012–2017	315	10 (6.7,13.3)
Hailu et al. [22]	2018	Tigray	Adult	2008–2016	260	18 (13.3,22.7)
Getaneh et al. [31]	2019	National	Adult	2016–2017	9284	22 (21.2,22.8)
Endebu et al. [26]	2018	Oromia	Adult	2013–2018	445	9 (6.3,11.7)

ISSN: 2397-0642